YJB Port Ltd v M&A Pharmachem Ltd & Anor [2021] EWHC 42 (Ch) (12 January 2021)

YJB Port Ltd v M&A Pharmachem Ltd & Anor [2021] EWHC 42 (Ch) (12 January 2021)

The proven breaches of clause 3(f) by M&A Pharmachem Limited were preparatory, internal acts that did not cause any diminution in the capital value of YJB Port Limited's business as at February 2019. The loss of value was attributable to the threat of future competition and potential misuse of confidential information, not to the actionable breaches. Threatened breaches are not actionable and cannot augment the causative effect of actual breaches. Accordingly, YJB suffered no compensatable loss from the proven breaches and is not entitled to damages.

Citation
[2021] EWHC 42 (Ch)
Parties
Claimant: YJB Port Limited; First Defendant: M&A Pharmachem Limited; Second Defendant: CD Medical Limited
Jurisdiction
England and Wales
Judgment Date
12 January 2021
Procedural Posture
Commercial Contract Dispute (breach of Contract, Confidential Information) / Quantum Trial Following Split Trial Order; Liability Previously Determined
Outcome
Claim for damages dismissed; limited injunctive relief granted on confidential information claim
Legal Topics
Breach of Contract, Causation, Damages, Confidential Information, Anticipatory Breach, Injunctive Relief
Contract Law Commercial Law Confidential Information Breach of Contract Causation Damages Anticipatory Breach Injunctive Relief

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 3 Authorities cited 11 Party arguments 2
Sign in to unlock

Parties

YJB Port Limited

Claimant

M&A Pharmachem Limited

First Defendant

CD Medical Limited

Second Defendant

Procedural Posture

Commercial Contract Dispute (breach of Contract, Confidential Information) / Quantum Trial Following Split Trial Order; Liability Previously Determined

Legal Issues

  1. 1 Whether the specific breaches of clause 3(f) of the Agreement by M&A Pharmachem Limited caused any recoverable loss to YJB Port Limited as at February 2019
  2. 2 Whether threatened (anticipatory) breaches or the prospect of future competition are relevant to causation or damages for breach of contract
  3. 3 Whether YJB is entitled to final injunctive relief restraining use or disclosure of confidential information

Ratio Decidendi

The proven breaches of clause 3(f) by M&A Pharmachem Limited were preparatory, internal acts that did not cause any diminution in the capital value of YJB Port Limited's business as at February 2019. The loss of value was attributable to the threat of future competition and potential misuse of confidential information, not to the actionable breaches. Threatened breaches are not actionable and cannot augment the causative effect of actual breaches. Accordingly, YJB suffered no compensatable loss from the proven breaches and is not entitled to damages.

Court Disposition

Claim for damages dismissed; limited injunctive relief granted on confidential information claim

Orders

  • No damages awarded to YJB Port Limited for breach of clause 3(f)
  • Final injunction granted restraining Defendants from using or disclosing confidential information as defined by the first trial judge